Document is current
Any future updates will be listed below
-
Authors
Medrano Sandonas, Leonardo https://orcid.org/0000-0002-7673-3142
Van Rompaey, Dries
Fallani, Alessio
Hilfiker, Mathias
Hahn, David
Perez-Benito, Laura
Verhoeven, Jonas
Tresadern, Gary https://orcid.org/0000-0002-4801-1644
Kurt Wegner, Joerg
Ceulemans, Hugo
Tkatchenko, Alexandre https://orcid.org/0000-0002-1012-4854
-
Funding
Funding for this research was provided by:
Janssen Pharmaceuticals (Aquamarine)
Janssen Pharmaceuticals (Aquamarine)
EC | Horizon 2020 Framework Programme (956832)
EC | Horizon 2020 Framework Programme (956832)
Janssen Pharmaceuticals (Aquamarine)
Janssen Pharmaceuticals (Aquamarine)
Janssen Pharmaceuticals (Aquamarine)
Janssen Pharmaceuticals (Aquamarine)
Janssen Pharmaceuticals (Aquamarine)
Janssen Pharmaceuticals (Aquamarine)
Janssen Pharmaceuticals (Aquamarine)
- License Information
-
More Information
Article History
Received: 18 March 2024
Accepted: 13 June 2024
First Online: 7 July 2024
Competing interests
: The authors declare no competing interests.
